Generex Announces Approval to Market Noninjectible Insulin

Generex Biotechnology Corporation, a leader in the area of buccal drug delivery, announced that Oral-lyn, its proprietary oral insulin spray formulation, has been approved for commercial marketing and sale by the Ecuadorian Ministry of Public Health for the treatment of both Type 1 and Type 2 diabetes.

Yahoo News (http://biz.yahoo.com/prnews/050503/sftu107.html?.v=8)